Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Newman NJ, Bruce BB, Biousse V (2025) GLP-1 RAs for idiopathic intracranial hypertensiontime for a trial
Its active ingredients are small molecules that have been individually marketed as drugs for applications other than weight loss 58
Saturated long chain fatty acids as possible natural alternative antibacterial agents: Opportunities and challenges
There are many interactions between vascular disease and AD and few agents exploring therapeutic opportunities regarding this interaction
Identification of senkyunolide I metabolites in rats using ultra performance liquid chromatography/quadrupole-time-of-flight tandem mass spectrometry
Semaglutide has already changed the conversation around type 2 diabetes, obesity, and cardiometabolic risk
